These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28242844)

  • 1. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
    Hsu JY; Roy JA; Xie D; Yang W; Shou H; Anderson AH; Landis JR; Jepson C; Wolf M; Isakova T; Rahman M; Feldman HI;
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1181-1189. PubMed ID: 28242844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Mehta R; Cai X; Lee J; Xie D; Wang X; Scialla J; Anderson AH; Taliercio J; Dobre M; Chen J; Fischer M; Leonard M; Lash J; Hsu CY; de Boer IH; Feldman HI; Wolf M; Isakova T;
    Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
    Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
    JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular disease, ESRD, and death: interpreting competing risk analyses.
    Grams ME; Coresh J; Segev DL; Kucirka LM; Tighiouart H; Sarnak MJ
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1606-14. PubMed ID: 22859747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
    De Nicola L; Minutolo R; Chiodini P; Borrelli S; Zoccali C; Postorino M; Iodice C; Nappi F; Fuiano G; Gallo C; Conte G;
    Kidney Int; 2012 Aug; 82(4):482-8. PubMed ID: 22622495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ; Streja E; Sumida K; Soohoo M; Ravel VA; Gaipov A; Potukuchi PK; Thomas F; Rhee CM; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1428-1437. PubMed ID: 28679562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV; Ritchie JP; Middleton R; Larsson A; Larsson TE; Kalra PA
    Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
    Lim HJ; Zhang X; Dyck R; Osgood N
    BMC Med Res Methodol; 2010 Oct; 10():97. PubMed ID: 20964855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
    Trivin C; Metzger M; Haymann JP; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Stengel B; Thervet E;
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):957-64. PubMed ID: 25979978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?
    Haider DG; Masghati S; Goliasch G; Fuhrmann V; Soleiman A; Wolzt M; Baierl A; Druml W; Hörl WH
    J Nephrol; 2014 Dec; 27(6):643-51. PubMed ID: 24609889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pathogen-specific clinical mastitis in the first 100 days of first lactation with productive lifetime: An observational study comparing competing risks models for death and sale with the Cox model.
    Hertl JA; Schukken YH; Tauer LW; Welcome FL; Gröhn YT
    Prev Vet Med; 2023 Apr; 213():105879. PubMed ID: 36841041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
    Deo R; Katz R; de Boer IH; Sotoodehnia N; Kestenbaum B; Mukamal KJ; Chonchol M; Sarnak MJ; Siscovick D; Shlipak MG; Ix JH
    Am J Kidney Dis; 2015 Jul; 66(1):40-6. PubMed ID: 25572028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease.
    Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
    Korean J Intern Med; 2019 Jul; 34(4):858-866. PubMed ID: 29172403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, ESRD, and death in CKD.
    Navaneethan SD; Schold JD; Kirwan JP; Arrigain S; Jolly SE; Poggio ED; Beddhu S; Nally JV
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):945-52. PubMed ID: 23411425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.